Recent Research Analysts’ Ratings Changes for McKesson Corporation (MCK)

Recent Research Analysts’ Ratings Changes for McKesson Corporation (MCK)

McKesson Corporation (NYSE: MCK) has recently received a number of price target changes and ratings updates:

McKesson Corporation (NYSE:MCK) opened at 136.74 on Monday. The firm has a market cap of $29.00 billion, a PE ratio of 16.22 and a beta of 1.06. The firm has a 50-day moving average of $144.79 and a 200-day moving average of $163.24. McKesson Corporation has a 52-week low of $114.53 and a 52-week high of $199.43.

The company also recently declared a quarterly dividend, which will be paid on Monday, April 3rd. Stockholders of record on Wednesday, March 1st will be paid a dividend of $0.28 per share. This represents a $1.12 annualized dividend and a dividend yield of 0.82%. The ex-dividend date of this dividend is Monday, February 27th. McKesson Corporation’s dividend payout ratio (DPR) is presently 13.25%.

In related news, EVP Lori A. Schechter acquired 692 shares of the company’s stock in a transaction that occurred on Wednesday, November 30th. The stock was purchased at an average price of $144.52 per share, for a total transaction of $100,007.84. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, Director Wayne A. Budd sold 723 shares of McKesson Corporation stock in a transaction dated Monday, December 5th. The stock was sold at an average price of $145.77, for a total value of $105,391.71. The disclosure for this sale can be found here. Insiders own 1.15% of the company’s stock.

McKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally.

Related posts

Leave a Comment